Previous Close | 0.1924 |
Open | 0.2100 |
Bid | 0.2100 x 0 |
Ask | 0.2190 x 321800 |
Day's Range | 0.2100 - 0.2100 |
52 Week Range | 0.1500 - 0.4710 |
Volume | |
Avg. Volume | 136,156 |
Market Cap | 25.21M |
Beta (5Y Monthly) | 2.29 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0300 |
Earnings Date | Dec 12, 2024 - Dec 16, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
C21 Investments Inc. (CSE: CXXI) and (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced the filing of its interim unaudited financial statements and management discussion and analysis for its second quarter ending September 30, 2024, on SEDAR. The Company's financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles ("GAAP"). All currency is reported in U.S. dollars. The Company recently changed its fiscal rep
Over the last 7 days, the Canadian market has risen by 1.2%, contributing to a remarkable 28% increase over the past year, with earnings expected to grow by 16% annually in the coming years. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.